Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure
- 28 August 2000
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (3) , 838-844
- https://doi.org/10.1016/s0735-1097(00)00796-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)Published by Elsevier ,1997
- Biological Determinants of Aldosterone-Induced Cardiac Fibrosis in RatsHypertension, 1995
- The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarctionThe American Journal of Cardiology, 1995
- Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosisThe American Journal of Cardiology, 1995
- Collagen Metabolism in Cultured Adult Rat Cardiac Fibroblasts: Response to Angiotensin II and AldosteroneJournal of Molecular and Cellular Cardiology, 1994
- Mineralocorticoids, hypertension, and cardiac fibrosis.Journal of Clinical Investigation, 1994
- Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertensionThe American Journal of Cardiology, 1993
- Aldosterone and Dexamethasone Binding in Human Arterial Smooth Muscle CellsJournal Of Hypertension, 1987
- Captopril in heart failure. A double blind controlled trial.Heart, 1984